Know Cancer

or
forgot password

Screening for Breast Cancer in Patients Undergoing Myocardial Perfusion Imaging


N/A
18 Years
90 Years
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

Screening for Breast Cancer in Patients Undergoing Myocardial Perfusion Imaging


You are being asked to take part in this research study because you have been scheduled to
have a scan of your heart. The radioactive dye used to image your heart is also taken up by
many types of breast cancer. The investigators have developed a new method for detecting
breast cancer, called Molecular Breast Imaging that uses this dye.

The purpose of this study is to see how well this new method works in normal subjects with
no known breast cancer and to see if we can detect breast cancer at an earlier stage than
mammography. As you read this form describing the study, ask any questions you have. Take
your time to decide. Feel free to discuss the study with your family, friends, and
healthcare provider before you decide. You may stop participating at any time during the
study. You may decide not to participate. If so, none of your current benefits or normal
health care will be affected in any way. When you feel comfortable that all your questions
have been answered, and you wish to take part in this study, sign this form in order to
begin your participation. Your signature means you have been told about the study and what
the risks are. Your signature on this form also means that you want to take part in this
study.


Inclusion Criteria:



- They have had a mammogram at Mayo Clinic Rochester within the last 12 months

- Undergoing myocardial perfusion imaging

Exclusion Criteria:

- They are unable to understand and sign the consent form

- They are physically unable to sit upright and still for 20 minutes

- They have undergone breast surgery or breast biopsy within the last 12 months.

- They have had trauma to the breast tissue or undergone radiation treatment to the
breast within the last 12 months.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Biopsy-proven breast cancer

Outcome Time Frame:

12 months

Safety Issue:

No

Principal Investigator

Deborah J. Rhodes, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Institutional Review Board

Study ID:

08-001046

NCT ID:

NCT00943241

Start Date:

July 2008

Completion Date:

June 2010

Related Keywords:

  • Breast Cancer
  • Breast
  • Breast Cancer
  • MBI
  • Molecular Breast Imaging
  • Molecular Imaging
  • Breast Neoplasms

Name

Location

Mayo Clinic Rochester, Minnesota  55905